SHAWNA SAPAUGH: Open Payments
NPI 1932764529 · SEDALIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,130 in 54 payments from 14 companies in 2025. Trend: 2023 $613 · 2024 $802 · 2025 $1,130
Food & beverage: $1,130
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $318 |
| GENZYME CORPORATION | 12 | $221 |
| Grifols USA, LLC | 5 | $109 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $89 |
| Dexcom, Inc. | 3 | $77 |
| Verona Pharma, Inc. | 3 | $59 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Viatris Specialty LLC | 2 | $51 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
Products named: DUPIXENT, AIRSUPRA, Prolastin-C Liquid, FASENRA, OFEV, Dexcom G6 Transmitter, Ohtuvayre, NUCALA.
Industry payments across MO — which companies pay providers there.
